Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,679,354
-
Total 13F shares
-
70,841,695
-
Share change
-
+4,535,432
-
Total reported value
-
$143,815,507
-
Put/Call ratio
-
90%
-
Price per share
-
$2.03
-
Number of holders
-
96
-
Value change
-
+$8,057,833
-
Number of buys
-
40
-
Number of sells
-
39
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2023
As of 30 Sep 2023,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,841,695 shares.
The largest 10 holders included
Whitefort Capital Management, LP, BlackRock Inc., Two Seas Capital LP, VANGUARD GROUP INC, MORGAN STANLEY, Woodline Partners LP, Hudson Bay Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.